Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 11 to 14 amino acid residues in defined sequence
Patent
1995-08-18
2000-05-30
Feisee, Lila
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
11 to 14 amino acid residues in defined sequence
530300, 530350, C06K 706, C06K 14435
Patent
active
060692316
ABSTRACT:
The present invention provides PR domain peptides, which are about 100 to about 120 amino acids in length and contain three highly conserved sequences of about 10 to about 12 amino acids, separated by less conserved sequences of about 20 to about 35 amino acids.
REFERENCES:
George et al. Macromolecular Sequencing & Synthesis Selected Methods & Applications, pp. 127-149, 1988.
Bourne et al., "The GTPase superfamily: conserved structure and molecular mechanism." Nature, 349:117-127 (1991).
Boyd et al., "A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis." EMBO. J. 12:469-478 (1993).
Van Cherington et al., "Separation of simian virus 40 large T antigen transforming and origin-binding functions from the ability to block differentiation." Mol. Cell. Biol., 8:1380-1384 (1988).
DeCaprio et al., "SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene." Cell, 54:275-283 (1988).
Defeo-Jones et al., "Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product." Nature, 352:251-254 (1991).
Dowdy et al., "Physical interaction of the retinoblastoma protein with human D cyclins." Cell 73:499-511 (1993).
Durfee et al., "The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit." Genes Dev., 7:555-569 (1993).
Dyson et al., "Adenovirus E1A makes two distinct contacts with the retinoblastoma protein." J. Virol., 66:4606-4611 (1992).
Ewen et al., "Functional interactions of the retinoblastoma protein with mammalian D-type cyclins." Cell, 73:487-497 (1993).
Ford et al., "Nuclear protein with sequence homology to translation initiation factor eIF-4A." Nature, 332:736-738 (1988).
Harlow et al., "Association of adenovirus early region 1A proteins with cellular polypeptides." Mol. Cell. Biol., 6:1579-1589 (1986).
Hirling et al., "RNA helicase activity associated with the human p68 protein." Nature, 339:562-564 (1989).
Hu et al., "The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations." EMBO J., 9:1147-1155 (1990).
Huang et al., "Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen." EMBO J., 9:1815-1822 (1990).
Huang et al., "A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product." Nature, 350:160-162 (1991).
Huang et al., "The retinoblastoma protein region required for interaction with the E2F transcription factor includes the T/E1A binding and carboxy-terminal sequences." DNA Cell Biol., 11:539-548 (1992).
Kaelin, Jr. et al., "Definition of the minimal simian virus 40 large T Antigen and adenovirus E1A-binding domain in the retinoblastoma gene product." Mol. Cell. Biol., 10:3761-3769 (1990).
Keller and Maniatis, "Identification and characterization of a novel repressor of .beta.-interferon gene expression." Genes Dev., 5:868-879 (1991).
Kimelman et al., "E1a regions of the human adenoviruses and of the highly oncogenic simian adenovirus 7 are closely related." J. Virol., 53:399-409 (1985).
M. Kozak, "An analysis of 5' noncoding sequences from 699 vertebrate messenger RNAs." Nucl. Acids Res. 15:8125-8148 (1987).
Krieg and Melton, "Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs." Nucl. Acids Res., 12:7057-7070 (1984).
Lane and Hoeffler, "SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000." Nature, 288:167-170 (1980).
Lillie et al., "Functional domains of adenovirus type 5 E1a proteins." Cell, 50:1091-1100 (1987).
Ludlow et al., "SV40 large T antigen binds preferentially to an under phosphorylated member of the retinoblastoma susceptibility gene product family." Cell, 56:57-65 (1989).
Mihara et al., "Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product." Science, 246:1300-1303 (1989).
E. Moran, "A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products." Nature, 334:168-170 (1988).
Moran and Matthews, "Multiple functional domains in the adenovirus E1A gene." Cell, 48:177-178 (1987).
J.R. Nevins, "E2F: a link between the Rb tumor suppressor protein and viral oncoproteins." Science, 258:424-429 (1992).
Pawson and Gish, "SH2 and SH3 domains: from structure to function." Cell 71:359-362 (1992).
Qin et al., "Identification of a growth suppression domain within the retinoblastoma gene product." Genes Dev., 6:953-964 (1992).
Quinlan et al., "Growth factor induction by the adenovirus type 5 E1A 12S protein is required for immortilization of primary epithelial cells." Mol. Cell. Biol., 8:3191-3203 (1988).
Quinlan and Douglas, "Immortilization of primary epithelial cells requires first- and second-exon functions of adenovirus type 5 12S." J. Virol., 66:2020-2030 (1992).
Ren et al., "Identification of a ten-amino acid proline-rich SH3 binding site." Science, 259:1157-1161 (1993).
Saraste et al., "The P-loop--a common motif in ATP- and GTP-binding proteins." Trends. Biochem. Sci., 15:430-434 (1990).
Scheffner et al., "RNA unwinding activity of SV40 large T antigen." Cell 57:955-963 (1989).
Smith and Ziff, "The amino-terminal region of the adenovirus serotype 5 E1a protein performs two separate functions when expressed in primary baby rat kidney cells." Mol. Cell. Biol., 8:3882-3890 (1988).
Subramanian et al., "Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein." Oncogene, 4:415-420 (1989).
Templeton et al., "Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering." Proc. Natl. Acad. Sci. USA, 88:3033-3037 (1991).
Wang et al., "Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and the control of cell growth." J. Virol., 67:476-488 (1993).
R.A. Weinberg, "Tumor suppressor genes." Science, 254:1138-1146 (1991).
Welch and Wang, "A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle." Cell, 75:779-790 (1993).
Whyte et al., "Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product." Nature 334:124-129 (1988).
Whyte et al., "Cellular targets for transformation by the adenovirus E1A proteins." Cell, 56:67-75 (1989).
Walker et al., "Distantly related sequences in the .alpha.- and .beta.-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold." Embo J., 1(8):945-951 (1982).
Chen et al., "Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation." Cell, 58:1193-1198 (1989).
DeCaprio et al., "The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element." Cell, 58:1085-1095 (1989).
Iggo and Lane, "Nuclear protein p68 is an RNA-dependent ATPase." EMBO J., 8(6):1827-1831 (1989).
Moran et al., "Identification of separate domains in the adenovirus E1A gene for immortilization activity and the activation of virus early genes." Mol. and Cell. Biol., 6(10):3470-3480 (1986).
Buchkovich et al., "The retinoblastoma protein is phosphorylated during specific phases of the cell cycle." Cell, 58:1097-1105 (1989).
Chen et al., "Identification of a Human Homologue of Yeast Nuc2 Which Interacts with the Retinoblastoma Protein in a Specific Manner." Cell Growth & Differ. 6:199-210 (1995).
Bartholomew and Ihle, "Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter." Mol. Cell. Biol., 11(4):1820-1828 (1991).
Morishita et al., "Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiat
Feisee Lila
La Jolla Cancer Research Foundation
Saoud Christine
LandOfFree
PR domain peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PR domain peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PR domain peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1911145